These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Neuroendocrine Regulation of Food Intake in Polycystic Ovary Syndrome. Romualdi D; Immediata V; De Cicco S; Tagliaferri V; Lanzone A Reprod Sci; 2018 May; 25(5):644-653. PubMed ID: 28874103 [TBL] [Abstract][Full Text] [Related]
5. Alteration of ghrelin-neuropeptide Y network in obese patients with polycystic ovary syndrome: role of hyperinsulinism. Romualdi D; De Marinis L; Campagna G; Proto C; Lanzone A; Guido M Clin Endocrinol (Oxf); 2008 Oct; 69(4):562-7. PubMed ID: 18248643 [TBL] [Abstract][Full Text] [Related]
6. Serum leptin levels in women with polycystic ovary syndrome: the role of insulin resistance/hyperinsulinemia. Laughlin GA; Morales AJ; Yen SS J Clin Endocrinol Metab; 1997 Jun; 82(6):1692-6. PubMed ID: 9177365 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of ovarian functionality after a dietary treatment in obese women with polycystic ovary syndrome. Tolino A; Gambardella V; Caccavale C; D'Ettore A; Giannotti F; D'Antò V; De Falco CL Eur J Obstet Gynecol Reprod Biol; 2005 Mar; 119(1):87-93. PubMed ID: 15734091 [TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms of insulin resistance in polycystic ovary syndrome. Diamanti-Kandarakis E; Papavassiliou AG Trends Mol Med; 2006 Jul; 12(7):324-32. PubMed ID: 16769248 [TBL] [Abstract][Full Text] [Related]
10. Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome. Pehlivanov B; Mitkov M Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):153-9. PubMed ID: 19340711 [TBL] [Abstract][Full Text] [Related]
11. Polycystic ovary syndrome and insulin: our understanding in the past, present and future. Mayer SB; Evans WS; Nestler JE Womens Health (Lond); 2015 Mar; 11(2):137-49. PubMed ID: 25776288 [TBL] [Abstract][Full Text] [Related]
13. New markers of insulin resistance in polycystic ovary syndrome. Polak K; Czyzyk A; Simoncini T; Meczekalski B J Endocrinol Invest; 2017 Jan; 40(1):1-8. PubMed ID: 27473078 [TBL] [Abstract][Full Text] [Related]
14. Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study. Panidis D; Tziomalos K; Misichronis G; Papadakis E; Betsas G; Katsikis I; Macut D Hum Reprod; 2012 Feb; 27(2):541-9. PubMed ID: 22144419 [TBL] [Abstract][Full Text] [Related]
15. Serum kisspeptin, leptin, neuropeptide Y, and neurokinin B levels in adolescents with polycystic ovary syndrome. Guzelkas I; Orbak Z; Doneray H; Ozturk N; Sagsoz N J Pediatr Endocrinol Metab; 2022 Apr; 35(4):481-487. PubMed ID: 35170267 [TBL] [Abstract][Full Text] [Related]
16. Insulin action in the polycystic ovary syndrome. Dunaif A Endocrinol Metab Clin North Am; 1999 Jun; 28(2):341-59. PubMed ID: 10352922 [TBL] [Abstract][Full Text] [Related]
17. A study of ghrelin and leptin levels and their relationship to metabolic profiles in obese and lean Saudi women with polycystic ovary syndrome (PCOS). Daghestani MH; Daghestani M; Daghistani M; El-Mazny A; Bjørklund G; Chirumbolo S; Al Saggaf SH; Warsy A Lipids Health Dis; 2018 Aug; 17(1):195. PubMed ID: 30131073 [TBL] [Abstract][Full Text] [Related]
18. Abdominal adiposity and the polycystic ovary syndrome. Escobar-Morreale HF; San Millán JL Trends Endocrinol Metab; 2007 Sep; 18(7):266-72. PubMed ID: 17693095 [TBL] [Abstract][Full Text] [Related]
19. Is there a role for leptin in the endocrine and metabolic aberrations of polycystic ovary syndrome? Gennarelli G; Holte J; Wide L; Berne C; Lithell H Hum Reprod; 1998 Mar; 13(3):535-41. PubMed ID: 9572406 [TBL] [Abstract][Full Text] [Related]
20. [Ovarian insulin resistance and insulin sensitizer effect on polycystic ovary syndrome]. Wu XK; Risto E Zhonghua Fu Chan Ke Za Zhi; 2004 Dec; 39(12):804-8. PubMed ID: 15733404 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]